Cost-effectiveness analysis of the fixed combined oral treatment with tramadol/acetaminophen (tramacet®) for the management of lower back pain at the IMSS (Mexican institute of social security)

被引：0
|
作者：
Vazquez, V.
Sumano, I
机构：
[1] Janssen Cilag Mexico, Mexico City, DF, Mexico
[2] Janssen Cilag Ciudad De Mexico, Mexico City, DF, Mexico
来源：
VALUE IN HEALTH | 2007年 / 10卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)69064-X
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A173 / A173
页数：1
相关论文
共 13 条
  • [1] COST-EFFECTIVENESS ANALYSIS OF CELECOXIB FOR THE MANAGEMENT OF LOW BACK PAIN AT THE SOCIAL SECURITY MEXICAN INSTITUTE
    Arreola-Ornelas, H.
    Rosado-Buzzo, A.
    Garcia-Mollinedo, L.
    Dorantes-Aguilar, L.
    Mucino-Ortega, E.
    Mould-Quevedo, J. F.
    [J]. VALUE IN HEALTH, 2010, 13 (03) : A210 - A210
  • [2] Cost-effectiveness of acute and chronic rhinosinusitis at the Mexican Institute of Social Security (IMSS)
    Munoz-Carlin, M. D. L.
    Nevarez-Sida, A.
    Garcia-Contreras, F.
    Mendieta-Sevilla, S. R.
    Constantino-Casas, P.
    [J]. VALUE IN HEALTH, 2007, 10 (03) : A159 - A159
  • [3] COST ANALYSIS OF TREATMENT IN PATIENTS SOFT TISSUE SARCOMA WITH EARLY IN THE MEXICAN INSTITUTE OF SOCIAL SECURITY (IMSS)
    Rely, K.
    Salinas, E. G.
    Silva, A.
    Lara, G. P.
    [J]. VALUE IN HEALTH, 2009, 12 (07) : A494 - A494
  • [4] THE COST-EFFECTIVENESS OF DELAYED RELEASE DIMETHYL FUMARATE VERSUS GLATIRAMER ACETATE FOR THE TREATMENT OF RELAPSING REMITTING MULTIPLE SCLEROSIS IN THE MEXICAN SOCIAL SECURITY INSTITUTE (IMSS)
    de Anda, J. A.
    Noda, C.
    Anaya, P.
    Azamar, A.
    Machado, M.
    Serafini, P.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A432 - A432
  • [5] COST-EFFECTIVENESS OF DABIGATRAN ETEXILATE IN THE PROPHYLAXIS OF VENOUS THROMBOEMBOLIC DISEASE (VTE) ASSOCIATED WITH HIP SURGERY IN THE ADULT PATIENT IN THE MEXICAN INSTITUTE OF SOCIAL SECURITY (IMSS)
    Ledezma-Gomez, H.
    Heredia-Miranda, E.
    Gasca-Pineda, R.
    [J]. VALUE IN HEALTH, 2009, 12 (07) : A503 - A503
  • [6] COMPARATIVE ANALYSIS OF COST-EFFECTIVENESS BEVACIZUMAB plus PACLITAXEL VERSUS USING ONLY VERSUS PACLITAXEL AS FIRST LINE TREATMENT OF PATIENTS WITH METASTATIC BREAST CANCER IN THE IMSS (MEXICAN INSTITUTE OF SOCIAL SECURITY)
    Arreola Ornelas, H.
    Rosado Buzzo, A.
    Garcia, L.
    Camacho, L. M.
    Lechuga, D.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A451 - A451
  • [7] COST-EFFECTIVENESS ANALYSIS OF ERTAPENEN VS THE PATTERS OF ANTIBIOTICS ROUTINELY USED FOR THE TREATMENT OF DIABETIC FOOT INFECTIONS AT THE SOCIAL SECURITY MEXICAN INSTITUTE
    Contreras, I
    Balderas-Pena, L. M. A.
    Sat-Munoz, D.
    Aranza-Aguilar, J. L.
    Canales-Munoz, J. L.
    Barrera-Cardenas, C., V
    Balderas-Pena, C. A.
    [J]. VALUE IN HEALTH, 2010, 13 (03) : A190 - A191
  • [8] Cost-effectiveness analysis of adjuvant docetaxel, doxorubicin and cyclophosphamide regimen (TAC) versus 5-fluorouracil, doxorubicin and cyclophosphamide (FAC) in early breast cancer at the Mexican Social Security Institute (IMSS) Mexico
    Valle-Solis, Aura A. Erazo
    Olivares, Guillermo
    Lazaro, Miguel
    Maurel, Frederique
    Robles, Jesus
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 107 - 107
  • [9] Cost-effectiveness analysis of pregabalin for treatment of chronic low back pain in patients with accompanying lower limb pain (neuropathic component) in Japan
    Igarashi, Ataru
    Akazawa, Manabu
    Murata, Tatsunori
    Taguchi, Toshihiko
    Sadosky, Alesia
    Ebata, Nozomi
    Willke, Richard
    Fujii, Koichi
    Doherty, Jim
    Kobayashi, Makoto
    [J]. CLINICOECONOMICS AND OUTCOMES RESEARCH, 2015, 7 : 505 - 520
  • [10] COST-EFFECTIVENESS ANALYSIS OF A HOSPITAL CARE AT HOME PROGRAM VERSUS INPATIENT HOSPITAL CARE IN PATIENTS OF THE MEXICAN INSTITUTE OF SOCIAL SECURITY IN MEXICO CITY
    Azamar Alonso, A.
    Mena Brito, J.
    Soto Molina, H.
    [J]. VALUE IN HEALTH, 2014, 17 (03) : A135 - A135
12